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Abstract. The aim of this research was to study the antidiabetic activity of root 
extract of Ruellia tuberosa L. on rats (Rattus novergicus) induced by multiple 
low doses of streptozotocin. The parameters investigated were blood glucose 
levels, protease activities, and the histopathologic profiles of the kidneys. Three 
groups of rats, i.e. control, diabetic, and treatment, were used. R. tuberosa L. 
extracts were given orally for treatment at a dose of 250 mg/kg body weight per 
day for 21 consecutive days. The induced diabetes group treated with root extract 
of R. tuberosa L. (group III) had 60.3% lower glucose levels (119 mg/dL) 
compared to the group with induced diabetes only. Moreover, antidiabetic 
activity of R. tuberosa L extract was evidenced by the 55% lower protease 
activity in the treatment group compared to the untreated diabetic group. Finally, 
a positive effect from root extract of R. tuberosa L. was shown from the less 
damaged renal glomerulus and smaller gap between extracellular matrices and 
epithelium cells in the histopathologic profiles of the kidneys in the extract 
treatment group. These results show the potential of root extract of R. tuberosa 
L. as a natural product anti-diabetic agent. 
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1 Introduction 
Diabetes mellitus (DM), a heterogeneous group of disorders characterized by 
high blood glucose levels, is considered to be one of the major public health 
concerns. The pancreatic β-cell and its secretory product insulin are central in 
the pathophysiology of diabetes [1,2]. The prevalence of diabetes has reached 
epidemic proportions and is continuously increasing worldwide. The number of 
people with diabetes is projected to more than double by 2030 from 171 million 
to 366 million people [3]. A similar trend is observed in Indonesia. Data from 
the Ministry of Health Republic of Indonesia states that in 2006, there were 
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approximately 8.4 million people in Indonesia who suffered from diabetes. This 
number is predicted to increase to 21.3 million people by 2030 [4].  
In the prevention of diabetes, drug consumption is complementary alongside 
diet therapy. Oral antidiabetic drugs may be useful for people who are allergic 
to insulin or do not use insulin injections. However, the use of these drugs in the 
long term has disadvantages, such as toxicity to kidneys and increasing the risk 
of heart attack [5]. Therefore, efforts to develop traditional medicines against 
diabetes is rising, particularly in developing countries, where natural sources are 
abundant [6,7].  
One of the natural products that can be used as an antidiabetic drug comes from 
the Acanthaceae family, genus Ruellia. In the traditional medicine world, R. 
tuberosa L. has been widely used as antipyretic, analgesic, and anti-
hypertensive [8]. R. tuberosa L., also known as pletekan, pletikan, or ciplukan, 
is a plant that is found in almost in every region in Indonesia. R. tuberosa L. 
contains several bioactive compounds, including flavonoids, glycosides, 
saponins, and carotenoids. Studies have been conducted on the use of R. 
tuberosa L. as a potential antidiabetic agent, e.g. it was found to reduce lipid 
levels [9] and decrease lipid oxides [10] in a diabetic rat model. The parts of R. 
tuberosa L that were used were their leaves and stems. However, the other parts 
of R. tuberosa L may also contain bioactive compounds that potentially have 
antidiabetic properties. In the present work, the antidiabetic properties of root of 
R. tuberosa L. were investigated in vivo using diabetic rats as animal models for 
type 1 diabetes.  
It is known that in the diabetic condition, hyperglycemia will lead to glucose 
auto oxidation, protein glycation, and these further accelerate formation of 
reactive oxygen species [11,12]. Formation of such reactive oxygen species 
increases lipid modification, DNA, and proteins in various tissues [12,13]. 
These conditions also lead to chronic complications in the organs, such as the 
kidneys. In the kidneys, filtration, reabsorption and augmentation processes 
occur [14]. Therefore, in this study, the effects of root extracts of R. tuberosa L. 
on the kidneys were investigated, including their effects on protease activities 
and histopathological profiles. 
2 Materials and Method 
2.1 Materials and Instrumentation 
R. tuberosa L. roots were received from Materia Medica, Kota Batu. The rats 
obtained from the Biosains Laboratory, Brawijaya University were Wistar 
strain, male, and aged about 2 months, with an average body weight of 150-
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180 g. The use of animals in this research has received ethical clearance from 
the Animal Care and Use Committee of Brawijaya University, No. 744-KEP-
UB. The following chemicals used were purchased from Merck and used as 
received: streptozotocin, citric acid, H2SO4, sodium citrate, NaCl, KCl, HCl, 
NaOH, Na2HPO4H2O, PBS (phosphate buffer saline), n-hexane (HPLC grade), 
ethanol, TCA (trichloroacetic acid), sodium thiosulfate solution, xylol, liquid 
and solid paraffin, paraformaldehyde, and hematoxylin-eosin stain. The 
instruments used were a UV-Vis spectrophotometer (Thermo Scientific), an 
Olympus BX51 microscope, and a digital glucometer (EasyTouch GCU).  
2.2 Preparation of Animal Model 
A week prior to the experiment, the rats were adapted in the animal house. The 
rats were divided into three groups: (I) control group; (II) diabetic group; and 
(III) treatment group, with 6 rats in each group. They were maintained in the 
animal house of the Biosains Laboratory, Brawijaya University. One hundred 
milligrams of streptozotocin was dissolved in 3 mL of citrate buffer at pH 4.5. 
A dose of 20 mg/kg of body weight was injected i.p. into the rats in groups II 
and III on 5 consecutive days, while the rats in group I (control) were injected 
with PBS only.  
2.3 Preparation of Root Extract of R. tuberosa L. 
Fresh roots of R. tuberosa L. were washed with distilled water and cut into 
small pieces. The root pieces were then dried to obtain their dry weight. A total 
of 1 kg of dried root pieces was crushed into powder. The root powder was 
macerated with n-hexane, the volume was 7.5 the weight of the powder. The 
liquid root extract was evaporated with a rotary evaporator at 40 C and 100 
rpm. 
2.4 Phytochemical Test of Root Extract of R. tuberosa L. 
The phytochemical qualitative tests were conducted for flavonoids, steroids, and 
triterpenoids. R. tuberosa L. extract (1 mL) was dissolved in 96% of ethanol, 
and heated at 50 C for 5 min, and then cooled. The conversion into a dark red 
solution upon addition of concentrated HCl (2-3 drops) and Mg powder (0.2 g) 
indicated the presence of flavonoids. R. tuberosa L. extract (1 mL) was 
dissolved in 1 mL of concentrated CH3COOH. The formation of a red-brownish 
solution after addition of concentrated H2SO4 indicated the presence of 
triterpenoids, while the formation of blue solution showed the presence of 
steroids. A positive result was obtained for the presence of triterpenoids (Figure 
1). 
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2.5 Treatment with Root Extract of R. tuberosa L. for Group III 
The rats in group III were treated with R. tuberosa L. root extract at a dose of 
250 mg/kg body weight per day for each rat on 21 consecutive days. Day 0 for 
treatment started after the rats in group II and III had elevated blood glucose 
levels or suffered from diabetes (more than 135 mg/dL). The blood glucose 
levels were monitored each week, or on day 7, day 14, and day 21, during the 
treatment. 
2.6 Measurement of Protease Activities in the Kidneys 
Unlike the blood glucose levels, protease activities were calculated in week 21 
or at the end of the assay. Measurement of protease activities was conducted by 
first isolating protease from the kidneys according to reported procedures [15]. 
A mixture of 500 ppm of casein, 300 μL of phosphate buffer solution at pH 7, 
and 100 μL of protease isolated from the kidneys was mixed and then incubated 
at 37 C for 60 min. A volume of 400 μL of 4% TCA solution was added to the 
mixture, allowed to stand for 30 min at room temperature, and centrifuged 4000 
rpm for 10 min. An aliquot of the resulting supernatant was diluted 5 with 
phosphate buffer; its absorbance was determined at 275 nm (maximum 
wavelength of tyrosine). The protease activities were calculated with the 
following formula in Eq. (1): 
Protease activities = ሾ்௬௥௢௦௜௡௘ሿ௠௢௟.௪௘௜௚௛௧ ௢௙ ்௬௥௢௦௜௡௘  ൈ  
௩
௣ ൈ ௤  ൈ 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟   (1) 
where: v = sample volume (mL); q = incubation time (min); and p = protease 
volume (mL). 
2.7 Hematoxylin-Eosin Staining for Kidney Histopathology 
Profiles 
The rat kidneys were fixed in formaldehyde, then soaked in 70% ethanol for 24 
h, 80% ethanol for 2 h, 90% ethanol for 20 min, 95% ethanol for 20 min, and 
finally absolute ethanol for 20 min. These steps were repeated three times. The 
kidneys were soaked in a xylol solution at room temperature twice, then in a 
xylol solution at 60 C for 30 min. Next, the kidneys were dipped in liquid 
paraffin. Finally, the kidneys were solidified in paraffin blocks.  
The next step was to slice these kidney blocks into thin slides to prepare for 
staining. The staining began with washing the slides with xylol, ethanol and 
water. The slides were then soaked into hematoxylin solution for about 10 min 
and then washed for 30 min with water. The slides were stained with eosin for 5 
min and then washed with water to remove any excess eosin. The slides were 
fixed with 70%, 80%, 90%, 95%, and absolute ethanol. The last step was 
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clearing the slides with xylol, after which they were dried at room temperature. 
The histopathologic features of the kidneys were observed visually using an 
Olympus BX51 microscope with 40 or 100 magnification. Histopathological 
images were taken with a digital camera. 
2.8 Statistical Data Analysis 
A Student’s t-test was used for statistical analysis of differences between two 
groups of samples, control and treatment, or between each treatment. A two-
sample independent t-test was applied to test the statistical significance between 
the control and treatment groups using the Origin 6.1 software application [16]. 
In all cases, any result with p < 0.05 was considered significant. 
 
Figure 1 The phytochemical qualitative test result of R. tuberosa L. extract for 
triterpenoids. A positive result was concluded from the color change from a 
yellow to a red-brownish solution. 
3 Results and Discussion 
The antidiabetic capacity of root extract of Ruellia tuberosa L. was tested first 
for its effect on the blood glucose levels on the diabetic rats. The results of the 
blood glucose levels for the rats from all groups on day 7, 14 and 21 are 
presented in Figure 1. It can be seen that there were significant increases (p < 
0.001) in the blood glucose levels of the mice in group II (diabetic rats) after the 
induction of streptozotocin, starting on day 7 and continuing until day 21. On 
day 21 it reached 30024.7 mg/dL. On day 21, the blood glucose levels of 
group III, i.e. after treatment with R. tuberosa L., were significantly lower 
(119.024.6 mg/dL; p < 0.01) compared to the blood glucose levels of the 
diabetic rats. These numbers are in the range of normal blood glucose levels for 
132 Anna Safitri, et. al. 
rats after 21 days, i.e. 50-135 mg/dL [17]. The blood glucose levels for group I 
remained in the range of normal blood glucose levels during the 21 days of the 
experiment, at 83.27.5 mg/dL. The blood glucose levels for group III were 
almost the same as those of the control rats in group I. 
These results suggest that R. tuberosa L root extract has the ability to lower 
blood glucose levels in diabetic rats. The lower blood glucose levels in the 
therapy group showed improvement of the pancreatic β-cells. The improvement 
of the β-cells in the pancreas may be affected by the presence of the secondary 
metabolites in R. tuberosa L. root extract. The lower blood glucose levels in the 
diabetic rats treated with R. tuberosa L. root extract can be associated with the 
presence of triterpenoids in the composition of R. tuberosa L. root extract. A 
preliminary phytochemical test was conducted and the result indicated that the 
root extract of R. tuberosa L. contained triterpenoids, as shown in Figure 1. This 
was deduced from the color change from an orange to a red-brownish solution.  
 
Figure 2 Profiles of blood glucose levels in rats from groups I (control), II 
(diabetes induction), and III (diabetes induction plus R. tuberosa L. extract), in 
day 7, 14, and 21. Significant differences were based on a Student’s t-test using a 
two-sample independent test: ** p < 0.01, *** p < 0.001, increased compared to 
control rats (group I); ## p < 0.01, decreased compared to diabetic rats (group II).  
Figure 3 presents protease activities in the kidney extracts from the 3 groups of 
rats on the last day of the experiment (day 21). The protease activities in the 
diabetic rats had increased markedly at (p < 0.01) to 1.30.2 mol/mL.min on 
day 21 of the assay. This increased up to 120.8% compared to the protease 
activities in the normal rats (0.510.1 mol/mL.min). However, in the rats 
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treated with streptozotocin and R. tuberosa L. root extract, the protease 
activities were significantly lowered (p < 0.01) to 0.70.1 mol/mL.min.  
The increases of protease activities in the diabetic rats indicated cell damage 
after induction of streptozotocin in the rats. The diabetic state, where the 
oxidative stress levels are high, will cause protease activities to increase. This is 
due to free radicals causing membrane proteins to be damaged and hence 
membrane integrity to be lost, thereby damaging the kidney tissues [18,19]. In 
treated rats, the lower protease activities may be a result of antioxidant activities 
contained within the R. tuberosa L. extract, such as triterpenoid compound. 
Previous studies [20,21] have shown that triterpenoids in the extracts of various 
plants can act as antioxidants and therefore are correlated with treatment of 
diabetes mellitus. 
 
Figure 3 Profiles of protease activities in rats from groups I (control), II 
(diabetes induction), and III (diabetes induction plus R. tuberosa L. extract), after 
21 days of treatment with R. tuberosa L. root extracts. Significant differences 
were based on a Student’s t-test using a two-sample independent test: ** p < 
0.01, increased compared to control rats (group I); ## p < 0.01, decreased 
compared to diabetic rats (group II).  
In order to determine the extent of damage and repair of the tissues in the 
kidneys, the histopathological profiles of the kidneys were examined (Figure 4). 
Microscopic observation of the renal glomerular histopathology of group II 
(diabetic rats) indicated dramatic degeneration of the renal glomerulus and 
tubular pathologic lesion. This was shown by the widening of the Bowman’s 
space, as indicated by the yellow arrow, and irregular epitheliums in the kidneys 
(Figure 4(b)). Previous work has also shown significant alterations in the 
glomeruli of the kidneys of diabetic rats [22]. The histopathological profiles of 
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the kidneys from group III (Figure 4(c)) indicated significant improvement of 
the glomerulus relative to those from group II, as shown by the narrowing in the 
Bowman’s space and repair in the order of the epithelium.  
However, even though improvement was visible in the kidney profiles of the 
treated rats, the kidneys in the treated rats were not returned back to the same as 
the kidneys profiles of the normal rats, as shown in Figure 4(a). This may be 
due to the single dose of treatment used, 250 mg/kg body weight, which may 
have been sub-optimal, resulting in incomplete repair of the kidneys. 
Figure 4 The histopathological profiles of kidneys of rats from: (a) group I 
(control); (b) group II (diabetes induction); and (c) group III (diabetes induction 
plus R. tuberosa L. extracts) after 21 days of treatment with R. tuberosa L. root 
extract. Yellow arrows indicate the Bowman’s space. 
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4 Conclusion 
This paper highlighted the anti-diabetic capacity of R. tuberosa L. extract in 
diabetic rats. This was indicated by a decrease in high blood glucose levels, a 
decrease in protease activities, repair in the protein profiles, and recovery in the 
histopathological profiles of the kidneys. The triterpenoid contained in the R. 
tuberosa L. extract may be responsible for the antidiabetic actions, even though 
the molecular mechanism of the treatment effects is still unclear. Further 
research is needed to investigate the molecular mechanisms of triterpenoid 
acting as anti-diabetic agent. 
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